Skip to main content

Beyond fixed serum vitamin B12 thresholds: A multivariable risk approach to reflex methylmalonic acid testing (NHANES 2011-2014)

In brief

Multivariable model detected 83% of elevated methylmalonic acid cases, versus 33% with B12 cutoff

In 10,174 US adults, a multivariable model identified 83.2% of people with elevated methylmalonic acid at a 5% risk threshold, compared with 33.4% using a fixed vitamin B12 cutoff. Adding kidney function improved discrimination, but the full model required more testing and performed poorly without recalibration; external validation is needed before clinical use.

Journal
Clinica chimica acta; international journal of clinical chemistry (Q1)
Published
7 November 2026
Study design
Cross-sectional study
Evidence level
Level 3, Low (CEBM 3b)
Authors
Zhenghan Huang
PMID
42998864
DOI
10.1016/j.cca.2026.122966

Why clinicians should know about it

  • Picked for Biochemistry (medical) (paper of the day, 12 November 2026): B12 and MMA testing strategy accounts for renal-function interference

Abstract

BACKGROUND: Reflex methylmalonic acid (MMA) testing is usually guided by fixed B12 thresholds, which may fail when kidney function is impaired. METHODS: We analysed 10,174 NHANES 2011-2014 adults with complex-survey weighting. Four prespecified B12 cutoffs were compared with multivariable logistic models for elevated MMA (≥271 nmol/L) using decision curve analysis. RESULTS: Weighted prevalence of elevated MMA was 8.9%. The 221 pmol/L cutoff had sensitivity 33.4% (9.4% at eGFR <45). Discrimination rose across a comparator ladder: dichotomised B12 0.623, continuous B12 0.690, B12 + eGFR 0.805, full model 0.819. ΔAUC over B12 alone was 0.128 (JKn 95% CI 0.100-0.157) overall and 0.052 (JKn 95% CI 0.032-0.071) with eGFR ≥60; post hoc temporal validation preserved discrimination (validation AUC 0.817). Grey-zone-refitted models retained discrimination (optimism-corrected AUC 0.71 for B12 + eGFR); frozen full-sample models were modest (AUC 0.651 two-variable, 0.669 full) and require local recalibration. At a 5% risk threshold the full model detected 83.2% of cases versus 33.4% for the cutoff-7.6 additional tests per additional case. Continuous-scale kidney-function interaction was sensitive to the test denominator (p = 0.028-0.096). CONCLUSIONS: Single B12 thresholds had limited sensitivity and no kidney-stratified threshold system was supported or validated. A multivariable model-using only B12 and eGFR-showed better discrimination and apparent net benefit than fixed cutoffs. Post-hoc grey-zone refits showed gains, but the frozen full-sample model showed poor grey-zone calibration; external validation is required before clinical use.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.